| Product Code: ETC7537906 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Axicabtagene Ciloleucel Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Axicabtagene Ciloleucel Market Revenues & Volume, 2021 & 2031F |
3.3 India Axicabtagene Ciloleucel Market - Industry Life Cycle |
3.4 India Axicabtagene Ciloleucel Market - Porter's Five Forces |
3.5 India Axicabtagene Ciloleucel Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Axicabtagene Ciloleucel Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Axicabtagene Ciloleucel Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.8 India Axicabtagene Ciloleucel Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Axicabtagene Ciloleucel Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 India Axicabtagene Ciloleucel Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Axicabtagene Ciloleucel Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in India |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Favorable government initiatives to promote advanced cancer treatments |
4.3 Market Restraints |
4.3.1 High costs associated with axicabtagene ciloleucel therapy |
4.3.2 Limited awareness among healthcare professionals and patients |
4.3.3 Regulatory challenges and approval processes for advanced therapies in India |
5 India Axicabtagene Ciloleucel Market Trends |
6 India Axicabtagene Ciloleucel Market, By Types |
6.1 India Axicabtagene Ciloleucel Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Axicabtagene Ciloleucel Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Axicabtagene Ciloleucel Market Revenues & Volume, By Miscellaneous Antineoplastic, 2021- 2031F |
6.1.4 India Axicabtagene Ciloleucel Market Revenues & Volume, By Other, 2021- 2031F |
6.2 India Axicabtagene Ciloleucel Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Axicabtagene Ciloleucel Market Revenues & Volume, By Large B-cell Lymphoma, 2021- 2031F |
6.2.3 India Axicabtagene Ciloleucel Market Revenues & Volume, By Follicular Lymphoma, 2021- 2031F |
6.2.4 India Axicabtagene Ciloleucel Market Revenues & Volume, By Other, 2021- 2031F |
6.3 India Axicabtagene Ciloleucel Market, By Dosage |
6.3.1 Overview and Analysis |
6.3.2 India Axicabtagene Ciloleucel Market Revenues & Volume, By Suspension, 2021- 2031F |
6.3.3 India Axicabtagene Ciloleucel Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.4 India Axicabtagene Ciloleucel Market Revenues & Volume, By Other, 2021- 2031F |
6.4 India Axicabtagene Ciloleucel Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Axicabtagene Ciloleucel Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 India Axicabtagene Ciloleucel Market Revenues & Volume, By Other, 2021- 2031F |
6.5 India Axicabtagene Ciloleucel Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 India Axicabtagene Ciloleucel Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 India Axicabtagene Ciloleucel Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 India Axicabtagene Ciloleucel Market Revenues & Volume, By Cancer Treatment Center, 2021- 2031F |
6.5.5 India Axicabtagene Ciloleucel Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Axicabtagene Ciloleucel Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 India Axicabtagene Ciloleucel Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 India Axicabtagene Ciloleucel Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 India Axicabtagene Ciloleucel Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India Axicabtagene Ciloleucel Market Import-Export Trade Statistics |
7.1 India Axicabtagene Ciloleucel Market Export to Major Countries |
7.2 India Axicabtagene Ciloleucel Market Imports from Major Countries |
8 India Axicabtagene Ciloleucel Market Key Performance Indicators |
8.1 Patient response rates to axicabtagene ciloleucel treatment |
8.2 Number of healthcare facilities offering axicabtagene ciloleucel therapy |
8.3 Patient access to axicabtagene ciloleucel treatment centers |
8.4 Rate of successful outcomes and remissions post axicabtagene ciloleucel therapy |
8.5 Number of ongoing clinical trials and research studies related to axicabtagene ciloleucel therapy |
9 India Axicabtagene Ciloleucel Market - Opportunity Assessment |
9.1 India Axicabtagene Ciloleucel Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Axicabtagene Ciloleucel Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Axicabtagene Ciloleucel Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.4 India Axicabtagene Ciloleucel Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Axicabtagene Ciloleucel Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 India Axicabtagene Ciloleucel Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Axicabtagene Ciloleucel Market - Competitive Landscape |
10.1 India Axicabtagene Ciloleucel Market Revenue Share, By Companies, 2024 |
10.2 India Axicabtagene Ciloleucel Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here